Results 81 to 90 of about 22,987 (189)

Evidence in Sports Medicine

open access: yesDeutsche Zeitschrift für Sportmedizin
The cohort of master athletes (MA), defined people older than 35 years taking part in competitive sport events, is a rapidly growing population. This athlete cohort acquires adequate and sport-specific medical care. Although physical exercise ...
Schöffl V   +14 more
doaj   +1 more source

PHARMACOTHERAPY OF SUPRAVENTRICULAR TACHYCARDIA

open access: yesРоссийский кардиологический журнал, 2009
.
Yu. A. Bunin
doaj  

New Russian antiarrhythmic agent nibentan: clinical effectiveness and pharmacokinetics in supraventricular arrhythmia management

open access: yesРоссийский кардиологический журнал, 2007
Clinical effectiveness of a new Russian antiarrhythmic agent nibentan, Class III, was studied in various supraventricular arrhythmias. In total, 220 patients with atrial fibrillation (AF), atrial flutter (AFl), supraventricular tachycardia (SVT) and ...
A. E. Radzevich   +6 more
doaj  

Dual Ventricular Response or 1 : 2 Atrioventricular Conduction in Dual Atrioventricular Nodal Physiology

open access: yesIndian Pacing and Electrophysiology Journal, 2008
Dual ventricular response to a single supraventricular impulse is an interesting possibility in the presence of dual atrioventricular nodal physiology. Double His bundle and ventricular responses to a single atrial impulse caused by a simultaneous fast ...
Krishnan MN, Johnson Francis
doaj  

PROPAFENONE, A NEW EFFECTIVE ANTIARRHYTHMIC DRUG. REPORT OF 2 YEARS CLINICAL EXPERIMENT WITH PROPAFENONE (WITH BRIEF REVIEW OF ARTICLES)

open access: yesActa Medica Iranica, 1986
Propafenone HCI (p), is a relatively new Class IC antiarrhythmic agent. It has been reported to be superior to conventional antiarrhythmics in the control of supraventricular, ventricular and WPW associated tachyarrhythmias.
IRAJ NAZERY    +1 more
doaj  

Home - About - Disclaimer - Privacy